Are we entering a new age for human vaccine adjuvants?O’Hagan, Derek T; Fox, Christopher B · Expert Review of Vaccines · 2015

New Metabolizable Immunologic Adjuvant for Human Use. 4. Development of Highly Purified Influenza Virus Vaccine in Adjuvant 65Woodhour, A. F.; Metzgar, D. P.; Lampson, G. P.; Machlowittz, R. A.; Tytell, A. A.; Hilleman, M. R. · Experimental Biology and Medicine · 1966

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccinesAucouturier, Jerome; Dupuis, L; Deville, S; Ascarateil, S; Ganne, V · Expert Review of Vaccines · 2002

New Metabolizable Immunologic Adjuvant for Human Use. 6. Disposition of Radioactivity after Administration of Labelled Vaccine To the RatPorter, C. C.; Titus, D. C. · Experimental Biology and Medicine · 1967

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerRammensee, Hans-Georg; Wiesmüller, Karl-Heinz; Chandran, P. Anoop; Zelba, Henning; Rusch, Elisa; Gouttefangeas, Cécile; Kowalewski, Daniel J.; Di Marco, Moreno; Haen, Sebastian P.; Walz, Juliane S.; Gloria, Yamel Cardona; Bödder, Johanna; Schertel, Jill-Marie; Tunger, Antje; Müller, Luise; Kießler, Maximilian; Wehner, Rebekka; Schmitz, Marc; Jakobi, Meike; Schneiderhan-Marra, Nicole; Klein, Reinhild; Laske, Karoline; Artzner, Kerstin; Backert, Linus; Schuster, Heiko; Schwenck, Johannes; Weber, Alexander N. R.; Pichler, Bernd J.; Kneilling, Manfred; la Fougère, Christian; Forchhammer, Stephan; Metzler, Gisela; Bauer, Jürgen; Weide, Benjamin; Schippert, Wilfried; Stevanović, Stefan; Löffler, Markus W. · Journal for ImmunoTherapy of Cancer · 2019